Test Price
2,800 AED✅ Home Collection Available
HLA Pre-Transplant Workup (Sensitized Recipient Panel 5) in Dubai, UAE | 2800 AED
Executive Summary & Core Metrics
This panel employs high-resolution HLA typing and crossmatching to detect preformed donor-specific antibodies (DSAs) that may trigger hyperacute or accelerated acute rejection in solid organ transplantation. It provides essential pre-transplant risk stratification for sensitized recipients.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The sensitized recipient panel 5 uses high-resolution Luminex xMAP® technology with reverse sequence-specific oligonucleotide probing (Reverse SSOP) combined with flow cytometry crossmatch (FCXM) to identify Class I and Class II HLA antibodies. This dual-platform approach delivers superior sensitivity and specificity compared to traditional complement-dependent cytotoxicity (CDC) crossmatching.
| Feature | Our Panel 5 Test | Alternative (CDC Crossmatch) |
|---|---|---|
| Precision | High-resolution Luminex xMAP® + Flow Cytometry | Low-resolution serological |
| Methodology | Reverse SSOP with Luminex X-Map + FCXM | Complement-Dependent Cytotoxicity |
| Speed (TAT) | 10–12 days | 5–7 days (lower sensitivity) |
Physician Insight & Safety Protocols
Transplant rejection carries life-threatening consequences, and this panel delivers essential pre-transplant risk stratification through high-resolution antibody detection. I interpret these results within the complete clinical context, accounting for prior sensitization events and antibody strength profiles. Clinical correlation with the recipient's sensitization history and donor antigen typing is imperative for accurate risk assessment.
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Safety Advisory
Maintain all prescribed immunosuppressive medications exactly as directed by your transplant physician. Abrupt discontinuation or dose modification must only be performed under direct clinical supervision. Any changes to your medication regimen require prior consultation with your managing clinical team.
Exclusion Criteria & Emergency Red Flags
- Active systemic infection or sepsis.
- Recent blood transfusion within 90 days (may interfere with antibody detection).
- Known hypersensitivity to contrast agents if imaging-guided biopsy is required.
Emergency Red Flags: Acute fever, graft site pain (if post-transplant), respiratory distress, or anaphylactic symptoms require immediate emergency intervention. Do not delay seeking urgent medical care.
Patient FAQ & Clinical Guidance
1. What is the HLA Pre-Transplant Workup Panel 5 and why is it necessary?
This panel detects pre-existing donor-specific antibodies (DSAs) that can cause hyperacute organ rejection, ensuring donor-recipient compatibility before transplant surgery. It is essential for sensitized recipients who have been exposed to foreign HLA antigens through prior transplantation, blood transfusion, or pregnancy.
2. How should I prepare for this test and what documents are required?
Both donor and recipient must provide blood samples in specified collection tubes. A physician prescription, valid identification documents, and signed consent in accordance with DHA requirements are mandatory. Our VIP mobile phlebotomy team coordinates directly with you and the transplant centre to ensure proper sample timing and handling.
3. When will I receive my results and does insurance cover the 2800 AED cost?
Results are typically available within 10–12 business days from sample receipt. Direct insurance billing verification can be obtained via WhatsApp at +971 54 548 8731. Our team assists with pre-authorisation documentation to streamline coverage assessment.
UAE Regulatory & Data Privacy Adherence
ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) | Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields | Federal Decree-Law No. 4 of 2016 on Medical Liability
All laboratory processes comply with UAE healthcare data protection standards. Patient information is encrypted, access-controlled, and processed exclusively within secure clinical information systems. Results are released only to authorised healthcare providers and patients with verified consent.
Clinical & Logistical Metadata
| Test Name | HLA Pre-Transplant Workup (Sensitized Recipient Panel 5) |
| Price (AED) | 2800 |
| Turnaround Time | 10–12 business days |
| Sample Type / Matrix | Peripheral Blood (Whole Blood, Serum) |
| Methodology Used | High-resolution Luminex xMAP® (Reverse SSOP) + Flow Cytometry Crossmatch (FCXM) |
| ICD-10-CM Code | Z02.83 |
| LOINC Code | 54478-2 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians